Three quarters of trusts in England still use paper patient notes and drug charts

Three quarters of trusts in England that responded to a survey by The BMJ are still reliant on paper patient notes and drug charts, despite progress towards electronic records and prescribing.

How Q1 2024 Could Be Vital for Cybin’s FDA Milestones

The Dales Report is here with a psychedelics exclusive podcast. In this episode of Trade To Black with CEO Doug Drysdale, we catch up with

January 26, 2024

Endocrine disruptors disproportionately harm low-income women

Exposure to some endocrine-disrupting chemicals (EDCs) that harm the thyroid gland has increased over the past 20 years among U.S. women of childbearing age and

June 3, 2024

Northwestern, Case Western Reserve develop Huntington’s therapy

The new treatment leverages peptide-brush polymers, which act as a shield to prevent proteins from binding to one another. Credit: Nathan Gianneschi/Northwestern University. Researchers from

November 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.